• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于给予奥比沙星的猫和狗尿液样本中分离出的代谢物的研究。

A study of metabolites isolated from the urine samples of cats and dogs administered orbifloxacin.

作者信息

Matsumoto S, Takahashi M, Kitadai N, Katae H

机构信息

Research Laboratories, Animal Science Division, Dainippon Pharmaceutical Co., Ltd., Osaka, Japan.

出版信息

J Vet Med Sci. 1998 Nov;60(11):1259-61. doi: 10.1292/jvms.60.1259.

DOI:10.1292/jvms.60.1259
PMID:9853310
Abstract

Urine samples of cats and dogs collected for 24 hr after a subcutaneous injection of orbifloxacin (OBFX) were analyzed. The metabolites were examined using HPLC. In the dog urine, 87% of total was the parent compound and 13% glucuronide compound of OBFX and 96% was parent and 4% metabolite in the cat urine. The metabolite of cat urine was identified as N-hydroxy OBFX, determined by comparison of the extraction of urine with chloroform with the standard compound of N-hydroxy OBFX, using LC/APCIMS. N-hydroxy OBFX had a weaker antibacterial activity against fluoroquinolone sensitive bacteria than the parent compound.

摘要

对皮下注射奥比沙星(OBFX)后24小时收集的猫和狗的尿液样本进行了分析。使用高效液相色谱法检测代谢产物。在狗尿液中,总量的87%为母体化合物,13%为OBFX的葡萄糖醛酸化合物;在猫尿液中,96%为母体,4%为代谢产物。通过将尿液用氯仿萃取物与N-羟基OBFX标准化合物进行比较,利用液相色谱/大气压化学电离质谱法鉴定出猫尿液中的代谢产物为N-羟基OBFX。N-羟基OBFX对氟喹诺酮敏感菌的抗菌活性比母体化合物弱。

相似文献

1
A study of metabolites isolated from the urine samples of cats and dogs administered orbifloxacin.一项关于给予奥比沙星的猫和狗尿液样本中分离出的代谢物的研究。
J Vet Med Sci. 1998 Nov;60(11):1259-61. doi: 10.1292/jvms.60.1259.
2
Assessment of urinary pharmacokinetics and pharmacodynamics of orbifloxacin in healthy dogs with ex vivo modelling.采用体外模型评估奥比沙星在健康犬体内的尿药代动力学和药效学。
J Med Microbiol. 2017 May;66(5):616-621. doi: 10.1099/jmm.0.000476. Epub 2017 May 4.
3
Determination of minimum biofilm eradication concentrations of orbifloxacin for canine bacterial uropathogens over different treatment periods.不同治疗期犬细菌性尿路病原体的奥比沙星最低生物膜根除浓度的测定
Microbiol Immunol. 2017 Jan;61(1):17-22. doi: 10.1111/1348-0421.12461.
4
A study of metabolites isolated from urine samples of pigs and calves administered orbifloxacin.一项对用奥比沙星给药的猪和小牛尿液样本中分离出的代谢物的研究。
J Vet Pharmacol Ther. 1999 Aug;22(4):286-9. doi: 10.1046/j.1365-2885.1999.00223.x.
5
Pharmacokinetics in plasma and alveolar regions of a healthy calf intramuscularly administered a single dose of orbifloxacin.健康犊牛肌肉注射单剂量氧氟沙星后,其血浆和肺泡区域的药代动力学。
J Vet Med Sci. 2022 Mar 15;84(3):400-405. doi: 10.1292/jvms.21-0517. Epub 2022 Jan 28.
6
Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration.单次静脉注射后麻醉犬体内恩诺沙星和环丙沙星的组织浓度。
Vet Ther. 2001 Spring;2(2):120-8.
7
Pharmacokinetic-pharmacodynamic integration of orbifloxacin in Japanese quail (Coturnix japonica) following oral and intravenous administration.口服和静脉注射后,奥比沙星在日本鹌鹑(Coturnix japonica)体内的药代动力学-药效学整合
J Vet Pharmacol Ther. 2011 Aug;34(4):350-8. doi: 10.1111/j.1365-2885.2010.01233.x. Epub 2010 Oct 11.
8
Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.5种氟喹诺酮类药物对犬猫病原体的药效学和药代动力学疗效指标比较。
J Vet Intern Med. 2006 Nov-Dec;20(6):1297-306. doi: 10.1892/0891-6640(2006)20[1297:copapi]2.0.co;2.
9
Pharmacokinetics of orbifloxacin in crucian carp (Carassius auratus) after intravenous and intramuscular administration.奥氟沙星静脉注射和肌肉注射后在鲫鱼(Carassius auratus)体内的药代动力学
J Vet Pharmacol Ther. 2018 Aug;41(4):599-604. doi: 10.1111/jvp.12495. Epub 2018 Feb 21.
10
Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of orbifloxacin in Korean Hanwoo cattle.奥比沙星在韩国韩牛中的药代动力学及药代动力学/药效学整合
J Vet Pharmacol Ther. 2009 Jun;32(3):219-28. doi: 10.1111/j.1365-2885.2008.01027.x.

引用本文的文献

1
Development and validation of a microbiological agar assay for determination of orbifloxacin in pharmaceutical preparations.开发并验证一种微生物琼脂检测法,用于测定药物制剂中的氧氟沙星。
Pharmaceutics. 2011 Aug 29;3(3):572-81. doi: 10.3390/pharmaceutics3030572.
2
Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms.猫科动物的药物代谢与处置:物种差异和分子机制的药代动力学证据
Vet Clin North Am Small Anim Pract. 2013 Sep;43(5):1039-54. doi: 10.1016/j.cvsm.2013.05.002.
3
Integration of pharmacokinetic and pharmacodynamic indices of orbifloxacin in beagle dogs after a single intravenous and intramuscular administration.
单次静脉注射和肌肉注射后比格犬奥比沙星的药代动力学和药效学指标整合
Antimicrob Agents Chemother. 2009 Jul;53(7):3024-9. doi: 10.1128/AAC.01346-08. Epub 2009 Apr 27.